You searched for subject:(Cancer colorectal)
.
Showing records 1 – 30 of
1405 total matches.
◁ [1] [2] [3] [4] [5] … [47] ▶
1.
Rogers, Charles Ray.
Colorectal Cancer Screening and Young African-American Men: Male Role Norms, Knowledge, Attitudes, and Perceptions.
Degree: 2013, Texas Digital Library
URL: http://hdl.handle.net/1969;
http://hdl.handle.net/2249.1/66704
► Of cancers affecting both men and women, colorectal cancer (CRC) is the second leading cancer to kill African Americans in the U.S. Compared to White…
(more)
▼ Of cancers affecting both men and women,
colorectal cancer (CRC) is the second leading
cancer to kill African Americans in the U.S. Compared to White men, African-American men have CRC incidence and mortality rates 20% and 45% higher, respectively. Owing to CRC???s high incidence and younger age at presentation among African-American men, CRC screening (CRCS) is warranted at age 45 rather than 50. Yet, most studies have focused on men older than 45. The findings of these studies suggest that CRC survival is inversely related to early detection, and advocate the continued need for development, testing, and translating prevention interventions into increase screening behavior. Hence, the two-fold purpose of this study was to (1) conduct a systematic review of the professional literature to assess African-American men???s knowledge, beliefs, and behaviors regarding CRCS; and (2) assess the knowledge, attitudes, male role norms, perceptions of subjective norms, and perceptions of barriers associated with CRCS among young adult African-American men (ages 19-45) employing survey research methodology. Utilizing Garrard???s Matrix Method, the systematic literature review synthesized 28 studies examining African-American men's knowledge, beliefs, and behaviors regarding CRCS. Six factors emerged as associated with CRCS intentions and behaviors: previous CRCS, CRC test preference, perceived benefits, perceived barriers, CRC/CRCS knowledge, and physician support/recommendation. In addition, the mean methodological quality score of 10.9 indicated these studies were, overall, of medium quality and suffered from specific flaws. The second component of this study – an on-line survey questionnaire – described the male role norms, knowledge, attitudes, perceived subjective norms, and perceived barriers associated with screening for CRC among a non-random sample of 157 young adult African-American men. Ultimately, family history of
cancer, work status, and perceived barriers were the critical factors associated with attitudes in all of our models/analyses. Of these, perceived barriers are the only factors amenable to change through health education efforts. Because this study was narrowly-focused on a specific group of African Americans, it provides a solid basis for developing structured health education interventions to increase young adult African-American men???s intention to screen for CRC.
Advisors/Committee Members: Goodson, Patricia (advisor).
Subjects/Keywords: Colorectal Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Rogers, C. R. (2013). Colorectal Cancer Screening and Young African-American Men: Male Role Norms, Knowledge, Attitudes, and Perceptions. (Thesis). Texas Digital Library. Retrieved from http://hdl.handle.net/1969; http://hdl.handle.net/2249.1/66704
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Rogers, Charles Ray. “Colorectal Cancer Screening and Young African-American Men: Male Role Norms, Knowledge, Attitudes, and Perceptions.” 2013. Thesis, Texas Digital Library. Accessed January 22, 2021.
http://hdl.handle.net/1969; http://hdl.handle.net/2249.1/66704.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Rogers, Charles Ray. “Colorectal Cancer Screening and Young African-American Men: Male Role Norms, Knowledge, Attitudes, and Perceptions.” 2013. Web. 22 Jan 2021.
Vancouver:
Rogers CR. Colorectal Cancer Screening and Young African-American Men: Male Role Norms, Knowledge, Attitudes, and Perceptions. [Internet] [Thesis]. Texas Digital Library; 2013. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/1969; http://hdl.handle.net/2249.1/66704.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Rogers CR. Colorectal Cancer Screening and Young African-American Men: Male Role Norms, Knowledge, Attitudes, and Perceptions. [Thesis]. Texas Digital Library; 2013. Available from: http://hdl.handle.net/1969; http://hdl.handle.net/2249.1/66704
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Wake Forest University
2.
McCabe, Eleanor.
TARGETED POLYMER NANOPARTICLES FOR THE DETECTION AND TREATMENT OF DISSEMINATED COLORECTAL CANCER IN VIVO.
Degree: 2018, Wake Forest University
URL: http://hdl.handle.net/10339/90738
► Colorectal cancer (CRC) is the second leading cause of cancer-related deaths and the fourth most common cancer in the United States. When CRC disseminates into…
(more)
▼ Colorectal cancer (CRC) is the second leading cause of cancer-related deaths and the fourth most common cancer in the United States. When CRC disseminates into the abdominal cavity, there can be hundreds, if not thousands, of small tumors infiltrating the surfaces of organs, making it extremely difficult to treat by conventional methods. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in combination with cytoreductive surgery (CRS) has improved the 5-year survival rate of late-stage CRC patients from 12% to 51%. However, the survival rates of these patients have stagnated, which emphasizes the need for more innovative approaches to improve patient survival outcomes.
Subjects/Keywords: Colorectal Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
McCabe, E. (2018). TARGETED POLYMER NANOPARTICLES FOR THE DETECTION AND TREATMENT OF DISSEMINATED COLORECTAL CANCER IN VIVO. (Thesis). Wake Forest University. Retrieved from http://hdl.handle.net/10339/90738
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
McCabe, Eleanor. “TARGETED POLYMER NANOPARTICLES FOR THE DETECTION AND TREATMENT OF DISSEMINATED COLORECTAL CANCER IN VIVO.” 2018. Thesis, Wake Forest University. Accessed January 22, 2021.
http://hdl.handle.net/10339/90738.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
McCabe, Eleanor. “TARGETED POLYMER NANOPARTICLES FOR THE DETECTION AND TREATMENT OF DISSEMINATED COLORECTAL CANCER IN VIVO.” 2018. Web. 22 Jan 2021.
Vancouver:
McCabe E. TARGETED POLYMER NANOPARTICLES FOR THE DETECTION AND TREATMENT OF DISSEMINATED COLORECTAL CANCER IN VIVO. [Internet] [Thesis]. Wake Forest University; 2018. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/10339/90738.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
McCabe E. TARGETED POLYMER NANOPARTICLES FOR THE DETECTION AND TREATMENT OF DISSEMINATED COLORECTAL CANCER IN VIVO. [Thesis]. Wake Forest University; 2018. Available from: http://hdl.handle.net/10339/90738
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Manitoba
3.
Delisle, Megan.
Variations in the quality and cost of colorectal cancer care in Manitoba.
Degree: Surgery, 2019, University of Manitoba
URL: http://hdl.handle.net/1993/34132
► Introduction: This thesis examines the quality of colorectal care and its association with healthcare costs. Methods: Quality of colorectal cancer care was assessed based on…
(more)
▼ Introduction:
This thesis examines the quality of
colorectal care and its association with healthcare costs.
Methods:
Quality of
colorectal cancer care was assessed based on geography and hospital volume in patients diagnosed with
colorectal cancer in Manitoba between 2004-2014. The associations between healthcare costs and longer wait times, higher postoperative morbidity and mortality and palliative care utilization were evaluated.
Results:
There were improvements in the quality of
colorectal cancer care between 2004-2014, but disparities by geography and hospital volume existed. Increasing healthcare costs were associated with longer wait times, higher rates of morbidity and mortality and underutilization of palliative care.
Conclusion:
The quality of
colorectal cancer care in Manitoba is improving but highly variable. This variability is an economic burden on the healthcare system and a cause of preventable patient morbidity and mortality. Strategies to improve the quality and reduce the costs of
colorectal cancer care in Manitoba are needed.
Advisors/Committee Members: McKay, Andrew (Surgery) (supervisor), Helewa, Ramzi (Surgery) Hochman, David (Surgery) Nashed, Maged (Radiology) (examiningcommittee).
Subjects/Keywords: Colorectal cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Delisle, M. (2019). Variations in the quality and cost of colorectal cancer care in Manitoba. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/34132
Chicago Manual of Style (16th Edition):
Delisle, Megan. “Variations in the quality and cost of colorectal cancer care in Manitoba.” 2019. Masters Thesis, University of Manitoba. Accessed January 22, 2021.
http://hdl.handle.net/1993/34132.
MLA Handbook (7th Edition):
Delisle, Megan. “Variations in the quality and cost of colorectal cancer care in Manitoba.” 2019. Web. 22 Jan 2021.
Vancouver:
Delisle M. Variations in the quality and cost of colorectal cancer care in Manitoba. [Internet] [Masters thesis]. University of Manitoba; 2019. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/1993/34132.
Council of Science Editors:
Delisle M. Variations in the quality and cost of colorectal cancer care in Manitoba. [Masters Thesis]. University of Manitoba; 2019. Available from: http://hdl.handle.net/1993/34132

University of Debrecen
4.
Chaviv, Sivan.
Pharmacology of Current Drugs in Adjuvant Chemotherapy of Colorectal Cancer
.
Degree: DE – Általános Orvostudományi Kar, 2014, University of Debrecen
URL: http://hdl.handle.net/2437/194722
► Colorectal cancer continues to be one of the most frequently diagnosed malignancies worldwide. While a curative treatment remains surgical excision, chemotherapy is an important treatment…
(more)
▼ Colorectal cancer continues to be one of the most frequently diagnosed malignancies worldwide. While a curative treatment remains surgical excision, chemotherapy is an important treatment in later stages, perhaps due its elimination of micrometastases that are not readily visible during surgery (not to mention its effect on larger metastases in stage IV disease).
Chemotherapeutic drugs currently approved for the use in adjuvant treatment of stage III and some cases of stage II
colorectal cancer are the fluoropyrimidines
5-fluorouracil and capecitabine (with or without the addition of folinic acid, which augments their action) and the platinum analog oxaliplatin. These drugs are used in several combination therapies that increase the disease-free survival and overall survival of patients.
This paper reviews the pharmacological aspects of these three chemotherapeutic agents and of folinic acid, which is a part of most regimens.
Advisors/Committee Members: Megyeri, Attila (advisor), University of Debrecen::Faculty of Medicine::Pharmacology and Pharmacotherapy (advisor).
Subjects/Keywords: Chemotherapy;
Colorectal cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Chaviv, S. (2014). Pharmacology of Current Drugs in Adjuvant Chemotherapy of Colorectal Cancer
. (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/194722
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Chaviv, Sivan. “Pharmacology of Current Drugs in Adjuvant Chemotherapy of Colorectal Cancer
.” 2014. Thesis, University of Debrecen. Accessed January 22, 2021.
http://hdl.handle.net/2437/194722.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Chaviv, Sivan. “Pharmacology of Current Drugs in Adjuvant Chemotherapy of Colorectal Cancer
.” 2014. Web. 22 Jan 2021.
Vancouver:
Chaviv S. Pharmacology of Current Drugs in Adjuvant Chemotherapy of Colorectal Cancer
. [Internet] [Thesis]. University of Debrecen; 2014. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/2437/194722.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Chaviv S. Pharmacology of Current Drugs in Adjuvant Chemotherapy of Colorectal Cancer
. [Thesis]. University of Debrecen; 2014. Available from: http://hdl.handle.net/2437/194722
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Southern California
5.
Sturgeon, Julia D.
Fish consumption and risk of colorectal cancer.
Degree: MS, Applied Biostatistics and Epidemiology, 2015, University of Southern California
URL: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/601425/rec/2826
► The association between fish consumption and risk of colorectal cancer was investigated in a population-based, incidence density case control study from northern Israel, the Molecular…
(more)
▼ The association between fish consumption and risk of
colorectal cancer was investigated in a population-based, incidence
density case control study from northern Israel, the Molecular
Epidemiology of
Colorectal Cancer study. Food frequency
questionnaire data were used from 1,869 cases and 1,777 controls
ascertained and recruited between March 31, 1998 and February 14,
2005. Questionnaire data included three specific fish categories:
canned tuna, mackerel/salmon/sardines, and cooked/fried fish.
Multivariate unconditional logistic regression was used to assess
the association between each fish consumption variable and risk of
colorectal cancer. After adjusting for age, sex, and ethnicity
consumption of canned tuna was associated with reduced risk of
colorectal cancer. Participants who consumed canned tuna had an 18%
reduced risk of
colorectal cancer compared to those who never
consumed canned tuna (odds ratio, 0.82; 95% confidence interval,
[0.71, 0.94]). Comparing the highest tertile of fish consumption
(1+ serving/week) to the lowest tertile of fish consumption (0
servings/month), canned tuna was associated with a 24% reduction of
colorectal cancer risk. Adjusting known risk factors and potential
confounders, consumption of mackerel/salmon/sardines was associated
with a 27% reduced risk of
colorectal cancer when comparing the
highest and lowest tertiles of consumption (1+ serving/week vs. 0
servings/month). Consumption of cooked/fried fish was not
associated with risk of
colorectal cancer at any level of
consumption. Data from this planned interim analysis suggest that
diets characterized by the consumption of canned tuna as well as
mackerel, salmon, and sardines are associated with reduced risk of
colorectal cancer. Cooked and fried fish consumption was not
associated with risk of
colorectal cancer. This finding is
consistent with animal studies that have examined the association
between omega-3 fatty acids and colon tumor growth, indicating that
omega-3 fatty acids inhibit colon carcinogenesis.
Advisors/Committee Members: Gruber, Stephen B. (Committee Chair), Stern, Mariana C. (Committee Member), Gauderman, William James (Committee Member).
Subjects/Keywords: colorectal cancer; fish
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Sturgeon, J. D. (2015). Fish consumption and risk of colorectal cancer. (Masters Thesis). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/601425/rec/2826
Chicago Manual of Style (16th Edition):
Sturgeon, Julia D. “Fish consumption and risk of colorectal cancer.” 2015. Masters Thesis, University of Southern California. Accessed January 22, 2021.
http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/601425/rec/2826.
MLA Handbook (7th Edition):
Sturgeon, Julia D. “Fish consumption and risk of colorectal cancer.” 2015. Web. 22 Jan 2021.
Vancouver:
Sturgeon JD. Fish consumption and risk of colorectal cancer. [Internet] [Masters thesis]. University of Southern California; 2015. [cited 2021 Jan 22].
Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/601425/rec/2826.
Council of Science Editors:
Sturgeon JD. Fish consumption and risk of colorectal cancer. [Masters Thesis]. University of Southern California; 2015. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll3/id/601425/rec/2826

University of New South Wales
6.
Law, Eleanor.
Coping with colorectal cancer: An investigation of stress appraisal, social support and telomere length in colorectal cancer patients and caregivers.
Degree: Clinical School - South Western Sydney, 2018, University of New South Wales
URL: http://handle.unsw.edu.au/1959.4/60248
;
https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51037/SOURCE2?view=true
► A diagnosis of colorectal cancer (CRC) and the treatment that follows is associated with considerable stress affecting both the patient and their caregiver. Whilst both…
(more)
▼ A diagnosis of
colorectal cancer (CRC) and the treatment that follows is associated with considerable stress affecting both the patient and their caregiver. Whilst both patients and caregivers encounter numerous psychological and physical challenges across the duration of the
cancer experience, the extent to which these challenges have an impact on both patients and caregivers can vary considerably. Positioned within the theoretical framework of the Transactional Model of Stress and Coping, this dissertation reports on two studies that explore the role of key variables, in accounting for differential outcomes in patients with CRC and their caregivers from a psychological and physiological perspective (through the measurement of telomere length). The first study was a qualitative study (n = 20), which explored patients’ and caregivers’ experiences of social support within a treatment setting and the factors that limit or facilitate such support. The framework method of analysis revealed four themes: the treating team was identified as a source of social support; changes in existing supports were highlighted; different dimensions of support were reported; and evidence of dyadic coping emerged.The second study explored two aims. The first aim was to explore relationships among telomere length, depression and anxiety, perceived social support, cognitive appraisal of health, and coping in patients and caregivers following a diagnosis of CRC (n = 72). No relationship between telomere length and other variables were found. The second aim was to explore whether variables from the Stress and Coping theoretical framework, namely patient/caregiver status, social support, appraisal and coping, would predict anxiety and depression in patients with CRC and their caregivers (n = 102). Hierarchical multiple regression analysis suggested differing results for anxiety and depression. Caregiver status and harm/loss appraisal were the only significant predictors of anxiety, while only harm/loss appraisal was a significant predictor of depression. The findings of the dissertation are discussed in relation to theoretical underpinnings, highlighting avenues for future research, together with possible directions for clinical practice. The dissertation also highlights new knowledge, research limitations and implications that can help improve the understanding of psychosocial outcomes for CRC patients and their caregivers.
Advisors/Committee Members: Girgis, Afaf, Clinical School - South Western Sydney, Faculty of Medicine, UNSW, Levesque, Janelle, Clinical School - South Western Sydney, Faculty of Medicine, UNSW, Lambert, Sylvie, Clinical School - South Western Sydney, Faculty of Medicine, UNSW.
Subjects/Keywords: Colorectal cancer; Psychosocial; Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Law, E. (2018). Coping with colorectal cancer: An investigation of stress appraisal, social support and telomere length in colorectal cancer patients and caregivers. (Doctoral Dissertation). University of New South Wales. Retrieved from http://handle.unsw.edu.au/1959.4/60248 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51037/SOURCE2?view=true
Chicago Manual of Style (16th Edition):
Law, Eleanor. “Coping with colorectal cancer: An investigation of stress appraisal, social support and telomere length in colorectal cancer patients and caregivers.” 2018. Doctoral Dissertation, University of New South Wales. Accessed January 22, 2021.
http://handle.unsw.edu.au/1959.4/60248 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51037/SOURCE2?view=true.
MLA Handbook (7th Edition):
Law, Eleanor. “Coping with colorectal cancer: An investigation of stress appraisal, social support and telomere length in colorectal cancer patients and caregivers.” 2018. Web. 22 Jan 2021.
Vancouver:
Law E. Coping with colorectal cancer: An investigation of stress appraisal, social support and telomere length in colorectal cancer patients and caregivers. [Internet] [Doctoral dissertation]. University of New South Wales; 2018. [cited 2021 Jan 22].
Available from: http://handle.unsw.edu.au/1959.4/60248 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51037/SOURCE2?view=true.
Council of Science Editors:
Law E. Coping with colorectal cancer: An investigation of stress appraisal, social support and telomere length in colorectal cancer patients and caregivers. [Doctoral Dissertation]. University of New South Wales; 2018. Available from: http://handle.unsw.edu.au/1959.4/60248 ; https://unsworks.unsw.edu.au/fapi/datastream/unsworks:51037/SOURCE2?view=true

Boston University
7.
Patel, Arzoo.
Effects of weight change on metachronous adenomatous polyps.
Degree: MS, Physician Assistant Program, 2017, Boston University
URL: http://hdl.handle.net/2144/26939
► BACKGROUND: Numerous epidemiologic studies have identified obesity as a vital risk factor for the development of colorectal cancer (CRC). More recently, obesity has been linked…
(more)
▼ BACKGROUND: Numerous epidemiologic studies have identified obesity as a vital risk factor for the development of colorectal cancer (CRC). More recently, obesity has been linked to the development of colorectal adenomatous polyps (adenomas), the precursor lesion of up to 80% of CRCs. The extent to which weight loss could reduce risk in obese patients is unclear.
PROPOSED PROJECT: The proposed study is a randomized clinical trial that aims to evaluate the relationship between weight reduction and the prevalence of recurrent (metachronous) adenomas among obese patients in a safety-net health care setting. The intervention group will participate in a comprehensive, individually structured weight loss program in order to achieve successful long-term weight loss. The control group will receive no special recommendations about weight loss other than as part of “usual care”. Anthropometric measures (weight in kilograms [kg], height in meters squared [m2] and body mass index [BMI]) will be monitored annually until the time of surveillance colonoscopy which will occur in accordance with the U.S. Multi-Society Task Force recommendations. Statistical methods will be used to compare rates of recurrent adenomas among the two study groups after adjustments for duration of follow-up and potential confounders.
CONCLUSION/SIGNIFICANCE: The results of this study will provide new evidence to support weight reduction as a preventive strategy for reducing CRC risk among obese patients.
Subjects/Keywords: Medicine; Colorectal adenoma; Colorectal adenomatous polyps; Colorectal cancer; Metachronous colorectal cancer; Metachronous colorectal polyps; Recurrent colorectal adenoma
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Patel, A. (2017). Effects of weight change on metachronous adenomatous polyps. (Masters Thesis). Boston University. Retrieved from http://hdl.handle.net/2144/26939
Chicago Manual of Style (16th Edition):
Patel, Arzoo. “Effects of weight change on metachronous adenomatous polyps.” 2017. Masters Thesis, Boston University. Accessed January 22, 2021.
http://hdl.handle.net/2144/26939.
MLA Handbook (7th Edition):
Patel, Arzoo. “Effects of weight change on metachronous adenomatous polyps.” 2017. Web. 22 Jan 2021.
Vancouver:
Patel A. Effects of weight change on metachronous adenomatous polyps. [Internet] [Masters thesis]. Boston University; 2017. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/2144/26939.
Council of Science Editors:
Patel A. Effects of weight change on metachronous adenomatous polyps. [Masters Thesis]. Boston University; 2017. Available from: http://hdl.handle.net/2144/26939

University of the Western Cape
8.
Fadaka, Adewale Oluwaseun.
MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
.
Degree: 2019, University of the Western Cape
URL: http://hdl.handle.net/11394/7161
► Colorectal cancer (CRC) is referred to as cancers that arise in the colon or rectum. Rectal cancer is most often defined as cancers originating within…
(more)
▼ Colorectal cancer (CRC) is referred to as cancers that arise in the colon or rectum. Rectal
cancer
is most often defined as cancers originating within 15 cm from the anal verge. The crude
incidence of CRC in sub-Sahara African populations has been found to be 4.04/100,000 (4.38
for men and 3.69 for women). CRC stage correlates well with survival/cure rates with the
majority of patients diagnosed with CRC presenting with advanced disease and a low
survival/cure rate.
Advisors/Committee Members: Klein, Ashwil (advisor), Pretorius, Ashley (advisor).
Subjects/Keywords: Colorectal cancer;
Cancer biomarkers;
Cancer;
Early detection
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Fadaka, A. O. (2019). MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
. (Thesis). University of the Western Cape. Retrieved from http://hdl.handle.net/11394/7161
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Fadaka, Adewale Oluwaseun. “MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
.” 2019. Thesis, University of the Western Cape. Accessed January 22, 2021.
http://hdl.handle.net/11394/7161.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Fadaka, Adewale Oluwaseun. “MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
.” 2019. Web. 22 Jan 2021.
Vancouver:
Fadaka AO. MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
. [Internet] [Thesis]. University of the Western Cape; 2019. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/11394/7161.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Fadaka AO. MicroRNAs as predictive biomarkers for diagnosis and prognosis of colorectal cancer using in silico approaches
. [Thesis]. University of the Western Cape; 2019. Available from: http://hdl.handle.net/11394/7161
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Universiteit Utrecht
9.
Muilwijk, M.
Effect of food components on colon cancer through microbial transformation in the colon.
Degree: 2013, Universiteit Utrecht
URL: http://dspace.library.uu.nl:8080/handle/1874/273782
► Because the mortaility rates for colorectal cancer are high, it is of importance that research is done so that risks can be reduced. A major…
(more)
▼ Because the mortaility rates for
colorectal cancer are high, it is of importance that research is done so that risks can be reduced. A major risk factor involved in the development of colon
cancer is the composition of the diet. Various strains of bacteria can act tumor promoting or can act against the risk of developing
cancer. A close interaction exists between food substances and the microbiota, as the microbiota can be modulated by food compounds and microbiotic enzymes can convert food compounds into other substances. Carbohydrates can be fermented to short-chain fatty acids (SCFAs) which act preventive, while proteolytic fermentation can lead to an increase in toxic substances that can act on the progression of
colorectal cancer. In future, research can be further focused on mechanisms behind these phenomena.
Advisors/Committee Members: Venema, Dr. K..
Subjects/Keywords: Colorectal cancer; microbial transformation; food
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Muilwijk, M. (2013). Effect of food components on colon cancer through microbial transformation in the colon. (Masters Thesis). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/273782
Chicago Manual of Style (16th Edition):
Muilwijk, M. “Effect of food components on colon cancer through microbial transformation in the colon.” 2013. Masters Thesis, Universiteit Utrecht. Accessed January 22, 2021.
http://dspace.library.uu.nl:8080/handle/1874/273782.
MLA Handbook (7th Edition):
Muilwijk, M. “Effect of food components on colon cancer through microbial transformation in the colon.” 2013. Web. 22 Jan 2021.
Vancouver:
Muilwijk M. Effect of food components on colon cancer through microbial transformation in the colon. [Internet] [Masters thesis]. Universiteit Utrecht; 2013. [cited 2021 Jan 22].
Available from: http://dspace.library.uu.nl:8080/handle/1874/273782.
Council of Science Editors:
Muilwijk M. Effect of food components on colon cancer through microbial transformation in the colon. [Masters Thesis]. Universiteit Utrecht; 2013. Available from: http://dspace.library.uu.nl:8080/handle/1874/273782
10.
Goranova, Teodora Evgenieva.
Genetic analysis of the process of colorectal carcinogenesis : 大腸癌発生過程の遺伝学的解析; ダイチョウガン ハッセイ カテイ ノ イデンシガクテキ カイセキ.
Degree: Nara Institute of Science and Technology / 奈良先端科学技術大学院大学
URL: http://hdl.handle.net/10061/4677
Subjects/Keywords: colorectal cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Goranova, T. E. (n.d.). Genetic analysis of the process of colorectal carcinogenesis : 大腸癌発生過程の遺伝学的解析; ダイチョウガン ハッセイ カテイ ノ イデンシガクテキ カイセキ. (Thesis). Nara Institute of Science and Technology / 奈良先端科学技術大学院大学. Retrieved from http://hdl.handle.net/10061/4677
Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Goranova, Teodora Evgenieva. “Genetic analysis of the process of colorectal carcinogenesis : 大腸癌発生過程の遺伝学的解析; ダイチョウガン ハッセイ カテイ ノ イデンシガクテキ カイセキ.” Thesis, Nara Institute of Science and Technology / 奈良先端科学技術大学院大学. Accessed January 22, 2021.
http://hdl.handle.net/10061/4677.
Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Goranova, Teodora Evgenieva. “Genetic analysis of the process of colorectal carcinogenesis : 大腸癌発生過程の遺伝学的解析; ダイチョウガン ハッセイ カテイ ノ イデンシガクテキ カイセキ.” Web. 22 Jan 2021.
Note: this citation may be lacking information needed for this citation format:
No year of publication.
Vancouver:
Goranova TE. Genetic analysis of the process of colorectal carcinogenesis : 大腸癌発生過程の遺伝学的解析; ダイチョウガン ハッセイ カテイ ノ イデンシガクテキ カイセキ. [Internet] [Thesis]. Nara Institute of Science and Technology / 奈良先端科学技術大学院大学; [cited 2021 Jan 22].
Available from: http://hdl.handle.net/10061/4677.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.
Council of Science Editors:
Goranova TE. Genetic analysis of the process of colorectal carcinogenesis : 大腸癌発生過程の遺伝学的解析; ダイチョウガン ハッセイ カテイ ノ イデンシガクテキ カイセキ. [Thesis]. Nara Institute of Science and Technology / 奈良先端科学技術大学院大学; Available from: http://hdl.handle.net/10061/4677
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.
11.
Kitajima, Takahito.
Vasohibin-1 Increases the Malignant Potential of Colorectal Cancer and Is a Biomarker of Poor Prognosis.
Degree: 博士(医学), 2017, Mie University / 三重大学
URL: http://hdl.handle.net/10076/14722
► Background: Vasohibin-1 (VASHI) is related to angiogenesis and poor prognosis in several types of cancers. However, the biological function and clinical significance of VASHI in…
(more)
▼ Background: Vasohibin-1 (VASHI) is related to angiogenesis and poor prognosis in several types of cancers. However, the biological function and clinical significance of VASHI in colorectal cancer (CRC) are not fully known. Materials and Methods: The associations between VASHI expression and clinicopathological features were investigated by immunohistochemistry in 429 CRC tissues. To evaluate the function of VASHI in vitro, small-interfering VASHT targeting RNA was transfected into human CRC cell lines. Results: We found that VASHI was highly expressed in the cytoplasm of CRC tissues. High VASHI expression in the cytoplasm was significantly associated with tumor progression, such as larger tumor size, advanced T-stage, lymph node metastasis, distant metastasis and poor prognosis. Moreover, a significant positive correlation was detected between VASH1 expression and microvessel density. VASHI siRNA inhibited CRC cell proliferation, migration, and invasion, and promoted anoikis. Conclusion: Overexpression of VASHI in CRC cells increased malignant potential and promoted metastasis.
本文 / Department of Gastrointestinal and Pediatric Surgery,Mie University Graduate School of Medicine
10
Subjects/Keywords: Colorectal cancer; vasohibin-1; angiogenesis
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Kitajima, T. (2017). Vasohibin-1 Increases the Malignant Potential of Colorectal Cancer and Is a Biomarker of Poor Prognosis. (Thesis). Mie University / 三重大学. Retrieved from http://hdl.handle.net/10076/14722
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Kitajima, Takahito. “Vasohibin-1 Increases the Malignant Potential of Colorectal Cancer and Is a Biomarker of Poor Prognosis.” 2017. Thesis, Mie University / 三重大学. Accessed January 22, 2021.
http://hdl.handle.net/10076/14722.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Kitajima, Takahito. “Vasohibin-1 Increases the Malignant Potential of Colorectal Cancer and Is a Biomarker of Poor Prognosis.” 2017. Web. 22 Jan 2021.
Vancouver:
Kitajima T. Vasohibin-1 Increases the Malignant Potential of Colorectal Cancer and Is a Biomarker of Poor Prognosis. [Internet] [Thesis]. Mie University / 三重大学; 2017. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/10076/14722.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Kitajima T. Vasohibin-1 Increases the Malignant Potential of Colorectal Cancer and Is a Biomarker of Poor Prognosis. [Thesis]. Mie University / 三重大学; 2017. Available from: http://hdl.handle.net/10076/14722
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Alberta
12.
Ebadi, Maryam.
Alterations in adipose tissue in colorectal cancer
patients.
Degree: MS, Department of Agricultural, Food, and Nutritional
Science, 2012, University of Alberta
URL: https://era.library.ualberta.ca/files/pk02cb819
► Mechanisms underlying fat loss in cancer are not well understood. Knowing the types of fat being lost from adipose tissue may help define interventions to…
(more)
▼ Mechanisms underlying fat loss in cancer are not well
understood. Knowing the types of fat being lost from adipose tissue
may help define interventions to circumvent wasting. The aim of
this study was to explore the differences in adipokines and fatty
acid composition between visceral adipose tissue (VAT) and
subcutaneous (SAT) depots and relate this to fat mass changes
(expressed as %change /100d) assessed using computed tomography
images. Adipose tissue samples were obtained intraoperatively from
advanced colorectal cancer patients (n=16). The findings indicate
that fat was more commonly lost than gained. VAT was not preserved
in cancer patients throughout the disease progression. Greater
amounts of n-6 fatty acids in VAT were associated with greater fat
loss in cancer patients. There were higher levels of leptin in SAT
than VAT and higher monocyte chemotactic protein-1 (MCP-1) amounts
in VAT. Future work will investigate the mechanisms of fat loss in
cancer patients.
Subjects/Keywords: Colorectal cancer; Adipose tissue
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Ebadi, M. (2012). Alterations in adipose tissue in colorectal cancer
patients. (Masters Thesis). University of Alberta. Retrieved from https://era.library.ualberta.ca/files/pk02cb819
Chicago Manual of Style (16th Edition):
Ebadi, Maryam. “Alterations in adipose tissue in colorectal cancer
patients.” 2012. Masters Thesis, University of Alberta. Accessed January 22, 2021.
https://era.library.ualberta.ca/files/pk02cb819.
MLA Handbook (7th Edition):
Ebadi, Maryam. “Alterations in adipose tissue in colorectal cancer
patients.” 2012. Web. 22 Jan 2021.
Vancouver:
Ebadi M. Alterations in adipose tissue in colorectal cancer
patients. [Internet] [Masters thesis]. University of Alberta; 2012. [cited 2021 Jan 22].
Available from: https://era.library.ualberta.ca/files/pk02cb819.
Council of Science Editors:
Ebadi M. Alterations in adipose tissue in colorectal cancer
patients. [Masters Thesis]. University of Alberta; 2012. Available from: https://era.library.ualberta.ca/files/pk02cb819

Penn State University
13.
Ashmore, Joseph Henderson.
Dietary, Lifestyle, and Genetic Factors Influencing Colorectal Cancer Risk.
Degree: 2013, Penn State University
URL: https://submit-etda.libraries.psu.edu/catalog/17387
► Cancers of the colon and rectum (colorectum) are complex diseases that form through a combination of both intrinsic (e.g. genetic variation) and extrinsic (e.g. environmental)…
(more)
▼ Cancers of the colon and rectum (colorectum) are complex diseases that form through a combination of both intrinsic (e.g. genetic variation) and extrinsic (e.g. environmental) factors. Currently,
colorectal cancer (CRC) is the second leading
cancer killer in the United States and the fourth most common form of
cancer diagnosed. Many epidemiologic and laboratory studies have found that food and nutrition play an important role in both the incidence and progression of
colorectal cancers.
Data for the following studies were collected from adult men and women in central and northeastern Pennsylvania, which has higher CRC incidence and mortality rates than the United States average. Cases were identified from the Pennsylvania
cancer registry and population-based controls were identified via random-digit dialing. Dietary information was collected via a modified Diet History Questionnaire (DHQ) developed by Subar and colleagues at the National
Cancer Institute (NCI) including supplement use and an additional meat module. Sociodemographic, lifestyle, and buccal cells for genomic DNA analysis were collected during in-person interviews.
The objective of the first study was to examine
colorectal cancer risk associated with iron intake (total, dietary, supplemental, and heme). Heme iron content from the diet was calculated using a new heme iron database developed by the NCI using information from a detailed meat module that was added to the food frequency questionnaire. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using unconditional logistic regression. After multivariate adjustment, there were no significant associations between heme iron or total iron intake and CRC incidence. Dietary iron was inversely associated with
colorectal cancer risk in women (OR Q5 vs. Q1¬= 0.45; 95% CI = 0.22-0.92), but not men. Lastly, supplemental iron intake of >18 mg/d vs. none was positively associated with
colorectal cancer risk (OR = 2.31; 95% CI = 1.48-3.59; P-trend <0.001). In summary, these findings suggest that consumption of >18 mg/d of supplemental iron may increase risk for
colorectal cancer.
In the second study, our objective was to examine the associations between calcium and vitamin D intake (total, dietary, and supplemental) and incident
colorectal cancer. We found an inverse association between total vitamin D intake and
colorectal cancer risk (OR = 0.67; 95% CI = 0.49-0.91; P-trend < 0.01). Higher levels of total calcium intake were also inversely associated with
colorectal cancer incidence (OR Q5 v. Q1= 0.48; 95% CI = 0.35-0.66; P-trend <0.01). In addition, high supplemental intakes of vitamin D (>10 μg/d) and calcium (>500 mg/d) were associated with reduced risk (OR High v. None = 0.68; 95% CI = 0.53-0.89, P-trend = 0.05; OR High v. None = 0.61; 95% CI = 0.46-0.81, P-trend < 0.01, respectively). Overall, our results indicate reduced risk of
colorectal cancer with higher total and supplemental intakes of vitamin D and calcium.
In our final study, we examined the associations between folate intake (total,…
Advisors/Committee Members: Terryl Johnson Hartman, Dissertation Advisor/Co-Advisor, Terryl Johnson Hartman, Committee Chair/Co-Chair, Connie Jo Rogers, Committee Member, Shannon Leanne Kelleher, Committee Member, Arthur Steven Berg, Committee Member, Samuel M Lesko, Committee Member.
Subjects/Keywords: Colorectal cancer; nutrition; genetics
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Ashmore, J. H. (2013). Dietary, Lifestyle, and Genetic Factors Influencing Colorectal Cancer Risk. (Thesis). Penn State University. Retrieved from https://submit-etda.libraries.psu.edu/catalog/17387
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Ashmore, Joseph Henderson. “Dietary, Lifestyle, and Genetic Factors Influencing Colorectal Cancer Risk.” 2013. Thesis, Penn State University. Accessed January 22, 2021.
https://submit-etda.libraries.psu.edu/catalog/17387.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Ashmore, Joseph Henderson. “Dietary, Lifestyle, and Genetic Factors Influencing Colorectal Cancer Risk.” 2013. Web. 22 Jan 2021.
Vancouver:
Ashmore JH. Dietary, Lifestyle, and Genetic Factors Influencing Colorectal Cancer Risk. [Internet] [Thesis]. Penn State University; 2013. [cited 2021 Jan 22].
Available from: https://submit-etda.libraries.psu.edu/catalog/17387.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Ashmore JH. Dietary, Lifestyle, and Genetic Factors Influencing Colorectal Cancer Risk. [Thesis]. Penn State University; 2013. Available from: https://submit-etda.libraries.psu.edu/catalog/17387
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Waterloo
14.
Dekker, Heather.
Characterising changes in adhesion and enzyme activity related to drug resistance in colon cancer cells.
Degree: 2018, University of Waterloo
URL: http://hdl.handle.net/10012/14278
► Metastatic colorectal cancer is often fatal, and drug resistance to chemotherapeutic agents is one of the primary contributing factors to this lethality. Drug resistance arises…
(more)
▼ Metastatic colorectal cancer is often fatal, and drug resistance to chemotherapeutic agents is one of the primary contributing factors to this lethality. Drug resistance arises from exposure to chemotherapies, and it can be mediated through a variety of mechanisms. One of these mechanisms is alteration of enzymes within the cancer cells to affect the processing or removal of the drug. Carboxylesterase is an example of an enzyme that converts irinotecan, a drug used in metastatic colorectal cancer treatments, into the active metabolite SN-38. Carboxylesterase enzymes are found in high quantities in both the liver and intestinal cells. The presence of carboxylesterase in intestinal and liver cells is an important consideration in the processing of colorectal cancer treatments. Glutathione S-transferase is another enzyme that has been implicated in drug resistance because of its ability to conjugate reduced glutathione to xenobiotic substances, facilitating their removal. Additionally, drug resistance can affect the behaviours of cells. Drug-resistant cells can exhibit changes in their motility and aggressiveness compared to drug-sensitive cells. In this study I investigated cellular behavioural changes in SN-38-resistant colon cancer cells compared to their SN-38-sensitive counterparts. In addition to behavioural changes, I also sought to determine if elevations in carboxylesterase and glutathione S-transferase enzymes were contributing to the drug resistance in these colon cancer cells.
Subjects/Keywords: drug resistance; colorectal cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Dekker, H. (2018). Characterising changes in adhesion and enzyme activity related to drug resistance in colon cancer cells. (Thesis). University of Waterloo. Retrieved from http://hdl.handle.net/10012/14278
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Dekker, Heather. “Characterising changes in adhesion and enzyme activity related to drug resistance in colon cancer cells.” 2018. Thesis, University of Waterloo. Accessed January 22, 2021.
http://hdl.handle.net/10012/14278.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Dekker, Heather. “Characterising changes in adhesion and enzyme activity related to drug resistance in colon cancer cells.” 2018. Web. 22 Jan 2021.
Vancouver:
Dekker H. Characterising changes in adhesion and enzyme activity related to drug resistance in colon cancer cells. [Internet] [Thesis]. University of Waterloo; 2018. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/10012/14278.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Dekker H. Characterising changes in adhesion and enzyme activity related to drug resistance in colon cancer cells. [Thesis]. University of Waterloo; 2018. Available from: http://hdl.handle.net/10012/14278
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Queens University
15.
Hamilton, Leah.
The Diagnostic Interval of Colorectal Cancer Patients in Ontario by Degree of Rurality
.
Degree: Community Health and Epidemiology, 2015, Queens University
URL: http://hdl.handle.net/1974/13760
► Background: Wait times while moving through the cancer diagnostic process are a public health concern. Rural populations may experience more challenges in accessing cancer care,…
(more)
▼ Background: Wait times while moving through the cancer diagnostic process are a public health concern. Rural populations may experience more challenges in accessing cancer care, which could translate into a longer diagnostic interval and represent a healthcare inequity. This project analyzed the association between rurality of residence and the diagnostic interval of colorectal cancer (CRC) patients in Ontario, Canada.
Methods: This was a retrospective population-based cohort study. We used administrative databases available through the Institute for Clinical Evaluative Sciences (ICES) to identify incident CRC cases diagnosed from Jan 1, 2007- May 31, 2012. We assigned each patient a rurality score, based on their census subdivision, and calculated the length of their diagnostic interval. We defined the diagnostic interval as the time (in days) between a patient’s first diagnostic-related encounter with the health care system to the CRC diagnosis date. Data linkage through ICES allowed us to describe variations in cancer stage and the diagnostic interval by degree of rurality of patient residence and to analyze associations through multivariable models taking into account potential confounders.
Results: Overall, the median diagnostic interval of the CRC cohort was 64 (IQR: 22-159) days and the 90th percentile was 288 days. Patients with stage I CRC had a longer median diagnostic interval than patients with stage IV CRC. Across rurality categories, a significant difference in median diagnostic interval was detected in the stage I stratum only, ranging from 58.5 to 108 days (p=0.0005), but with the most rural group having the shortest diagnostic interval. Results from adjusted multivariable models suggested that patients in mid-ranged rural categories had similar or longer diagnostic intervals compared to patients in the least rural category while patients in the most rural category maintained the shortest diagnostic intervals. Important covariates included age, comorbidities and CRC sub-site.
Conclusion: Our results do not support a rurality effect on stage or the diagnostic interval in the hypothesized direction. Estimates of a shorter interval in the most rural category, especially for stage I disease, call for a deeper analysis to better understand care delivery in those areas and patient characteristics that might affect the interval.
Subjects/Keywords: Rural
;
Diagnostic Interval
;
Colorectal Cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Hamilton, L. (2015). The Diagnostic Interval of Colorectal Cancer Patients in Ontario by Degree of Rurality
. (Thesis). Queens University. Retrieved from http://hdl.handle.net/1974/13760
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Hamilton, Leah. “The Diagnostic Interval of Colorectal Cancer Patients in Ontario by Degree of Rurality
.” 2015. Thesis, Queens University. Accessed January 22, 2021.
http://hdl.handle.net/1974/13760.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Hamilton, Leah. “The Diagnostic Interval of Colorectal Cancer Patients in Ontario by Degree of Rurality
.” 2015. Web. 22 Jan 2021.
Vancouver:
Hamilton L. The Diagnostic Interval of Colorectal Cancer Patients in Ontario by Degree of Rurality
. [Internet] [Thesis]. Queens University; 2015. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/1974/13760.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Hamilton L. The Diagnostic Interval of Colorectal Cancer Patients in Ontario by Degree of Rurality
. [Thesis]. Queens University; 2015. Available from: http://hdl.handle.net/1974/13760
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Toronto
16.
Oatway, Christina Marie.
Modelling colorectal cancer tumourigenesis using intestinal organoids.
Degree: 2018, University of Toronto
URL: http://hdl.handle.net/1807/91546
► Colorectal cancer is one of the most common cancers leading to death, thus a better understanding of the mechanisms that lead to tumour initiation and…
(more)
▼ Colorectal cancer is one of the most common cancers leading to death, thus a better understanding of the mechanisms that lead to tumour initiation and progression are required to develop novel therapeutics. Current models for the study of this disease involve two-dimensional cell culture as well as animal studies. These have their advantages, however they do not contain complexity or species-specific implications. Human derived intestinal organoids provide a model that demonstrates the complexity and hierarchy of stem cells to differentiated cells that could allow for further insight into the disease, yet they are not without their own disadvantages. Production of human intestinal organoids is inefficient, and time consuming. I developed a screen to increase the efficiency of production using a small library of tool compounds targeting epigenetic regulators.
M.A.S.
Advisors/Committee Members: Wrana, Jeffrey, Molecular and Medical Genetics.
Subjects/Keywords: colorectal cancer; intestinal organoids; 0306
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Oatway, C. M. (2018). Modelling colorectal cancer tumourigenesis using intestinal organoids. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/91546
Chicago Manual of Style (16th Edition):
Oatway, Christina Marie. “Modelling colorectal cancer tumourigenesis using intestinal organoids.” 2018. Masters Thesis, University of Toronto. Accessed January 22, 2021.
http://hdl.handle.net/1807/91546.
MLA Handbook (7th Edition):
Oatway, Christina Marie. “Modelling colorectal cancer tumourigenesis using intestinal organoids.” 2018. Web. 22 Jan 2021.
Vancouver:
Oatway CM. Modelling colorectal cancer tumourigenesis using intestinal organoids. [Internet] [Masters thesis]. University of Toronto; 2018. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/1807/91546.
Council of Science Editors:
Oatway CM. Modelling colorectal cancer tumourigenesis using intestinal organoids. [Masters Thesis]. University of Toronto; 2018. Available from: http://hdl.handle.net/1807/91546

University of Otago
17.
Volkova , Ekaterina.
The link between obesity, colorectal cancer progression and tumour angiogenesis
.
Degree: 2011, University of Otago
URL: http://hdl.handle.net/10523/2042
► A link between obesity and risk of colorectal cancer development is strongly supported by epidemiological studies. Several obesity-related factors are implicated in this relationship. Among…
(more)
▼ A link between obesity and risk of
colorectal cancer development is strongly supported by epidemiological studies. Several obesity-related factors are implicated in this relationship. Among them, insulin resistance, a direct consequence of excess body weight, is considered as one of the most important. However, the role of obesity and related conditions in disease progression and outcome in
colorectal cancer patients is not completely clear. This study investigated the contribution of obesity, insulin resistance and inflammation in
colorectal cancer progression and patient survival. As a potential mechanism that could mediate the effect of obesity on
colorectal cancer outcome, this study focused on tumour angiogenesis and on tumour resistance to chemotherapy.
Patient body mass index (BMI), body surface area, as well as circulating markers of obesity, insulin resistance, inflammation (insulin, C-peptide, insulin-like growth factor-1 (IGF-1), C-reactive protein (CRP) and adiponectin) and angiogenesis (angiopoietin-2 (Ang-2), VEGF-A) were analysed in a New Zealand cohort of 344
colorectal cancer patients in relation to each other, to markers of disease progression and to patient survival. The effect of obesity-related and inflammatory factors on one of the main regulators of angiogenesis, hypoxia-inducible factor-1 (HIF-1), in colon
cancer and stromal cells was analysed in vitro. Tumour angiogenesis was compared in two groups of
colorectal cancer patients with distinct metabolic characteristics using immunohistochemical staining of tumour samples and analysis of angiogenic proteins levels. The effect of insulin and IGF-1 on cellular responses to chemotherapy drugs (5-fluorouracil, oxaliplatin and irinotecan) in colon
cancer and endothelial cells was analysed in vitro.
In the
colorectal cancer patient cohort, serum CRP and Ang-2, but not other markers, were associated with more advanced tumour characteristics and with worse patient survival. The immunohistochemical analysis of tumour samples showed no difference in tumour angiogenesis between
colorectal cancer patients with different metabolic profiles. However, the results suggested that obesity-related factors may contribute to regulation of angiogenic pathways, and this was confirmed in vitro and in tumour tissue protein extracts. Finally, insulin and IGF-1 were shown to modulate the in vitro cellular response to chemotherapy drugs in colon
cancer and endothelial cells.
Advisors/Committee Members: Currie, Margaret (advisor).
Subjects/Keywords: tumour angiogenesis;
colorectal cancer;
obesity
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Volkova , E. (2011). The link between obesity, colorectal cancer progression and tumour angiogenesis
. (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/2042
Chicago Manual of Style (16th Edition):
Volkova , Ekaterina. “The link between obesity, colorectal cancer progression and tumour angiogenesis
.” 2011. Doctoral Dissertation, University of Otago. Accessed January 22, 2021.
http://hdl.handle.net/10523/2042.
MLA Handbook (7th Edition):
Volkova , Ekaterina. “The link between obesity, colorectal cancer progression and tumour angiogenesis
.” 2011. Web. 22 Jan 2021.
Vancouver:
Volkova E. The link between obesity, colorectal cancer progression and tumour angiogenesis
. [Internet] [Doctoral dissertation]. University of Otago; 2011. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/10523/2042.
Council of Science Editors:
Volkova E. The link between obesity, colorectal cancer progression and tumour angiogenesis
. [Doctoral Dissertation]. University of Otago; 2011. Available from: http://hdl.handle.net/10523/2042

University of Guelph
18.
Kondra, Roman.
Characterizing the Role of Nkd1 in Colorectal Cancer.
Degree: MS, Department of Molecular and Cellular Biology, 2015, University of Guelph
URL: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8682
► The Wnt signaling pathway is a highly conserved pathway critical for development and homeostasis of stem cells. Aberrant Wnt signaling causes developmental defects and disease.…
(more)
▼ The Wnt signaling pathway is a highly conserved pathway critical for development and homeostasis of stem cells. Aberrant Wnt signaling causes developmental defects and disease. Over 90% of
colorectal cancers (CRC) contain mutations in Wnt signaling which constitutively activate the Wnt pathway independent of a Wnt ligand. Nkd1 is a negative feedback regulator of Wnt signaling and functions by binding and preventing nuclear accumulation of the central signaling component, β-catenin. Nkd1 is upregulated in a large number of CRC but its function in CRC's is unknown. As NKD1 function is dependent on membrane localization it is hypothesized that Nkd1 is activated by the binding of a Wnt ligand to its receptors. To explore NKD1's function and activation, cancerous and mammalian cell lines were used to examine NKD1's response to Wnt. Results show that, under Wnt stimulation the distribution of NKD1 changes and interaction between NKD1 and β-catenin increases.
Advisors/Committee Members: Van Raay, Terry (advisor).
Subjects/Keywords: Wnt; Colorectal Cancer; Nkd1
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Kondra, R. (2015). Characterizing the Role of Nkd1 in Colorectal Cancer. (Masters Thesis). University of Guelph. Retrieved from https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8682
Chicago Manual of Style (16th Edition):
Kondra, Roman. “Characterizing the Role of Nkd1 in Colorectal Cancer.” 2015. Masters Thesis, University of Guelph. Accessed January 22, 2021.
https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8682.
MLA Handbook (7th Edition):
Kondra, Roman. “Characterizing the Role of Nkd1 in Colorectal Cancer.” 2015. Web. 22 Jan 2021.
Vancouver:
Kondra R. Characterizing the Role of Nkd1 in Colorectal Cancer. [Internet] [Masters thesis]. University of Guelph; 2015. [cited 2021 Jan 22].
Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8682.
Council of Science Editors:
Kondra R. Characterizing the Role of Nkd1 in Colorectal Cancer. [Masters Thesis]. University of Guelph; 2015. Available from: https://atrium.lib.uoguelph.ca/xmlui/handle/10214/8682
19.
Abdelhady, Rasha.
Characterizing pro-mutagenic O6-alkylguanine adducts in
human colorectal tissue.
Degree: 2018, University of Manchester
URL: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:313114
► Colorectal cancer is the third most commonly diagnosed cancer worldwide. The positive association between red and/or processed meat consumption and human colorectal cancer risk is…
(more)
▼ Colorectal cancer is the third most commonly
diagnosed
cancer worldwide. The positive association between red
and/or processed meat consumption and human
colorectal cancer risk
is well established potentially via heme-catalysed formation of
carcinogenic N-nitrosocompounds (NNOC). These NNOC can form a range
of O6- alkylguanine (O6-alkylG) adducts that may increase
mutational and
cancer risk. The overall aim of this study was to
develop a novel approach to characterize the overall load of
O6-alkylG adducts in human
colorectal DNA using the known action of
the DNA repair protein, O6-alkylguanine O6-alkyltransferase (MGMT)
to irreversibly transfer the alkyl group from O6-alkylG to the MGMT
active site peptide (MGMT-ASP). Incubation of chemically
synthesised single (SS) and double stranded (DS)
oligodeoxyribonucleotides (ODNs) containing O6-methylguanine
(O6-MeG), O6- carboxyethylguanine (O6-CEG), but only DS
O6-carboxymethylguanine (O6-CMG) -23 mer containing ODNs with MGMT
resulted in MGMT inactivation. There was a preference for repair of
DS ODNs. Recorded IC50 values were 0.17+0.02, 0.07+0.01, 15.7+2.1,
27.00+1.70 and 7.50+0.50 nanomolar (nM) for SS O6-MeG, DS O6-MeG,
DS O6-CMG, SS O6-CEG, and DS O6-CEG, respectively. This repair was
confirmed using a restriction endonuclease site deprotection assay
as O6-MeG and O6-CEG inhibition of PstI digestion of ODNs, whilst,
O6-CMG inhibited MboI. This inhibition was removed by
pre-incubation with MGMT. Alkyl group transfer from these ODNs to a
Maltose binding protein-MGMT (MBP-MGMT) fusion protein was
demonstrated as alkylated active site peptides (ASPs) were detected
using with Matrix assisted laser desorption/ionizationtime of
flight (MALDI-TOF). S-methylcysteine (m/z 1329.7), and
S-carboxyethylcysteine (m/z 1387.7) modified ASPs were detected
following incubation of MBP-MGMT incubated with SS or DS O6-MeG,
and O6-CEG ODNs, respectively. Scarboxymethylcysteine (m/z 1373.7)
was detected with DS but not SS O6-CMG 23 mer ODN. Only the
unmodified MGMT-ASP (m/z 1315.7) was found after incubating MGMT
with unmodified ODN. Quantitative mass spectrometry (MS) findings
highlighted that MGMT preferentially repaired specified adducts
when presented in DS ODNs over SS ones. Temozolomide (TMZ)
methylated calf thymus DNA (CT-DNA) and human
colorectal cancer DNA
samples were incubated with his tagged MGMT fusion protein
(his-MGMT) and his-MGMT recovered using Ni-coated beads, digested
in situ with trypsin and analysed by MALDI-TOF. MS analysis of
tryptic digests of MGMT incubated with methylated CT-DNA revealed
methylated MGMT-ASP, detecting as low as 50 fmole of O6-MeG/mg
CT-DNA. This approach was applied to 13 human
colorectal DNA
samples, 12 of them showed evidence of O6 alkylation damage. Of 13
samples, 12 contained O6-MeG, 8 contained O6-CMG and 1 contained
O6-HOEtG. A further 7 peaks were detected with a signal/noise (S/N)
ratio of >10, potentially, correspond to alkylated MGMT-ASP ions
but identities of the alkyl groups are as yet unknown. These
results demonstrate proof of…
Advisors/Committee Members: BARRAN, PERDITA P, Povey, Andrew, Barran, Perdita.
Subjects/Keywords: Colorectal cancer; O6-alkylguanine adducts
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Abdelhady, R. (2018). Characterizing pro-mutagenic O6-alkylguanine adducts in
human colorectal tissue. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:313114
Chicago Manual of Style (16th Edition):
Abdelhady, Rasha. “Characterizing pro-mutagenic O6-alkylguanine adducts in
human colorectal tissue.” 2018. Doctoral Dissertation, University of Manchester. Accessed January 22, 2021.
http://www.manchester.ac.uk/escholar/uk-ac-man-scw:313114.
MLA Handbook (7th Edition):
Abdelhady, Rasha. “Characterizing pro-mutagenic O6-alkylguanine adducts in
human colorectal tissue.” 2018. Web. 22 Jan 2021.
Vancouver:
Abdelhady R. Characterizing pro-mutagenic O6-alkylguanine adducts in
human colorectal tissue. [Internet] [Doctoral dissertation]. University of Manchester; 2018. [cited 2021 Jan 22].
Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:313114.
Council of Science Editors:
Abdelhady R. Characterizing pro-mutagenic O6-alkylguanine adducts in
human colorectal tissue. [Doctoral Dissertation]. University of Manchester; 2018. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:313114

University of Toronto
20.
Wang, Charlie Shihn Kaai.
Health Utilization Patterns of Colonic Stents in Colorectal Cancer: A Retrospective Population-based Cohort Analysis.
Degree: 2010, University of Toronto
URL: http://hdl.handle.net/1807/25502
► Introduction: This study describes the patterns of use and processes of care following colonic stent insertion for patients with colorectal cancer (CRC) in clinical practice.…
(more)
▼ Introduction: This study describes the patterns of use and processes of care following colonic stent insertion for patients with colorectal cancer (CRC) in clinical practice.
Methods: Ontario residents who had a colonic stent placed for CRC between 2000–2009 were identified using linked administrative databases. Baseline patient, physician, and institutional characteristics were extracted. The cohort was followed for death and health services utilization post-stent.
Results: Two hundred twenty-five patients were identified. Median overall survival post-stent insertion was 199 days (interquartile range [IQR] 153-282). Eighty-five (38%) patients required a subsequent intervention (abdominal surgery, restenting, and/or dilatation). Median intervention-free survival was 75 days (IQR 59-91). Following stent insertion, the average rate of ER visits was 2.4 visits per person-year of follow up (95% CI, 2.2-2.7) and the overall average days spent in hospital was 19 inpatient days per person-year (95% CI, 18-19).
Conclusions: In clinical practice, many patients required another intervention shortly after stent insertion; however, the rate of post-stent ER visits and inpatient hospital days was low.
MAST
Advisors/Committee Members: Paszat, Lawrence, Health Policy, Management and Evaluation.
Subjects/Keywords: Colorectal cancer; Stent; Obstruction; 0564
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Wang, C. S. K. (2010). Health Utilization Patterns of Colonic Stents in Colorectal Cancer: A Retrospective Population-based Cohort Analysis. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/25502
Chicago Manual of Style (16th Edition):
Wang, Charlie Shihn Kaai. “Health Utilization Patterns of Colonic Stents in Colorectal Cancer: A Retrospective Population-based Cohort Analysis.” 2010. Masters Thesis, University of Toronto. Accessed January 22, 2021.
http://hdl.handle.net/1807/25502.
MLA Handbook (7th Edition):
Wang, Charlie Shihn Kaai. “Health Utilization Patterns of Colonic Stents in Colorectal Cancer: A Retrospective Population-based Cohort Analysis.” 2010. Web. 22 Jan 2021.
Vancouver:
Wang CSK. Health Utilization Patterns of Colonic Stents in Colorectal Cancer: A Retrospective Population-based Cohort Analysis. [Internet] [Masters thesis]. University of Toronto; 2010. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/1807/25502.
Council of Science Editors:
Wang CSK. Health Utilization Patterns of Colonic Stents in Colorectal Cancer: A Retrospective Population-based Cohort Analysis. [Masters Thesis]. University of Toronto; 2010. Available from: http://hdl.handle.net/1807/25502

University of Toronto
21.
Fung, Thomas Anthony.
Characterizing effects of small molecule inhibition of WDR5 in colorectal cancer.
Degree: 2017, University of Toronto
URL: http://hdl.handle.net/1807/79378
► Abstract WDR5 is a core subunit of the MLL-WRAD methyltransferases, NSL-MOF acetyltransferases and MYC-MAX transcription factors. Dysregulation of these complexes has been implicated in numerous…
(more)
▼ Abstract
WDR5 is a core subunit of the MLL-WRAD methyltransferases, NSL-MOF acetyltransferases and MYC-MAX transcription factors. Dysregulation of these complexes has been implicated in numerous cancers. Despite links between colorectal cancer (CRC) and WDR5, little is known about its role. Using OICR11824, an internally developed novel chemical antagonist of WDR5, we investigated the biological effects of targeting the arginine binding pocket of WDR5 in CRC. Firstly, we evaluated the ability of OICR11824 to bind and disrupt WDR5-MLL interaction in cells. We then utilized OICR11824 and shRNA knockdown to investigate effects of WDR5 inhibition on proliferation in CRC cell lines. In addition, Western blot and RT-PCR were performed to confirm modulation of H3K4 methylation and expression of MYC-transcriptional targets. Finally, flow cytometry was used to evaluate effects of WDR5 inhibition on cell cycle. Our research shows that OICR11824 binds and inhibits the WDR5-MLL interaction. As well, OICR11824 displays a range of anti-proliferation potencies in CRC cell lines with the greatest sensitivity seen in COLO205 demonstrating a G1 accumulation and S-phase depletion. Finally, OICR11824 affects the actions of WDR5-complexes in MYC-WDR5 gene targets and H3K4 trimethylation. Our research provides new insights into the role of WDR5 in CRC and will contribute to not only developing new therapeutics against CRC, but will also help elucidate the role of WDR5 complexes in cancer.
M.Sc.
Advisors/Committee Members: Al-awar, Rima, Pharmacology.
Subjects/Keywords: Colorectal Cancer; Epigenetics; WDR5; 0307
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Fung, T. A. (2017). Characterizing effects of small molecule inhibition of WDR5 in colorectal cancer. (Masters Thesis). University of Toronto. Retrieved from http://hdl.handle.net/1807/79378
Chicago Manual of Style (16th Edition):
Fung, Thomas Anthony. “Characterizing effects of small molecule inhibition of WDR5 in colorectal cancer.” 2017. Masters Thesis, University of Toronto. Accessed January 22, 2021.
http://hdl.handle.net/1807/79378.
MLA Handbook (7th Edition):
Fung, Thomas Anthony. “Characterizing effects of small molecule inhibition of WDR5 in colorectal cancer.” 2017. Web. 22 Jan 2021.
Vancouver:
Fung TA. Characterizing effects of small molecule inhibition of WDR5 in colorectal cancer. [Internet] [Masters thesis]. University of Toronto; 2017. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/1807/79378.
Council of Science Editors:
Fung TA. Characterizing effects of small molecule inhibition of WDR5 in colorectal cancer. [Masters Thesis]. University of Toronto; 2017. Available from: http://hdl.handle.net/1807/79378

University of Adelaide
22.
Arentz, Georgia.
Proteomic and molecular analysis in colorectal cancer: validation of the biomarkers desmin, SET and CK8.
Degree: 2010, University of Adelaide
URL: http://hdl.handle.net/2440/63424
► There is potential for significant improvements to be made in the diagnosis, staging, treatment and monitoring of colorectal cancer (CRC). The elucidation of proteins and…
(more)
▼ There is potential for significant improvements to be made in the diagnosis, staging, treatment and monitoring of
colorectal cancer (CRC). The elucidation of proteins and pathways involved in CRC would aid in the development of biomarkers for detection, identify patients at risk of relapse and potentially give rise to new molecular targets of treatment. Laser microdissectio (LMD) was used with minimal labelling two-dimensional gel electrophoresis (2D DIGE) and mass spectrometry to identify proteins significantly increased in eight early stage paired tumour-normal tissues. Seventeen individual proteins were identified as upregulated by >2 fold (P<0.05). The role of the proteins cytokeratin 8 (CK8) and SET in CRC were chosen for further analysis. A third protein, desmin, was chosen from a pilot study performed using LMD and saturation labelling 2D DIGE for further analysis.
The protein desmin was identified as significantly upregulated in a pilot study that aimed to identify proteins with altered expression in the cancerous epithelium and surrounding microenvironment. Using immunofluorescence (IF), desmin expression levels in the tissue stroma of late stage tumours compared to early stage tumours was significantly increased, P<0.0001. The desmin expressing cells were identified to be pericytes, formed around mature vasculature as a result of angiogenic stimulation. From this work desmin appears to have potential use as a histopathology marker for the identification of late stage patients and may help identify patients who would not benefit from the current anti-angiogenic therapies due to the presence of mature tumour microvasculature.
Three isoforms of CK8 were found to be upregulated in the DIGE study, with each isoform containing the phosphoserine (PS) residues 23, 431 and 73. Western blotting showed significantly increased phosphorylation levels at these sites in tumour compared to normal tissues. The MAP kinase ERK is known to phosphorylate the 73 and 431 residues and 50% of CRC patients have mutations in the EGFR/Ras/Raf/MEK/ERK signalling pathway (KRAS or BRAF mutations) resulting in constitutive ERK activation. Inhibition of EGFR activation in Caco2 cells showed a significant decrease (P<0.0001) in PS73 and PS431 levels by 59% and 65% respectively, indicating that patients with KRAS or BRAF mutations may have significantly increased PS73 and PS431 levels. Previously it has been shown that high levels of CK8 phosphorylation may help to protect cells against caspase degradation and evasion of apoptosis. This is the first report of the differential expression of phospho-CK8 isoforms in CRC.
SET is a known inhibitor of the tumour suppressor PP2A, a component of the GSK3 β complex that targets β catenin for degradation in the Wnt signalling pathway. Ninety percent of CRC patients have Wnt signalling pathway mutations resulting in constitutive pathway activation. The effect of knocking down SET via siRNA on β catenin levels was analysed in SW480 with constitutive Wnt signalling and HEK293 with low levels of Wnt…
Advisors/Committee Members: Hardingham, Jennifer E. (advisor), Chataway, Timothy K. (advisor), School of Molecular and Biomedical Science (school).
Subjects/Keywords: proteomics; colorectal cancer; biomarkers
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Arentz, G. (2010). Proteomic and molecular analysis in colorectal cancer: validation of the biomarkers desmin, SET and CK8. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/63424
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Arentz, Georgia. “Proteomic and molecular analysis in colorectal cancer: validation of the biomarkers desmin, SET and CK8.” 2010. Thesis, University of Adelaide. Accessed January 22, 2021.
http://hdl.handle.net/2440/63424.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Arentz, Georgia. “Proteomic and molecular analysis in colorectal cancer: validation of the biomarkers desmin, SET and CK8.” 2010. Web. 22 Jan 2021.
Vancouver:
Arentz G. Proteomic and molecular analysis in colorectal cancer: validation of the biomarkers desmin, SET and CK8. [Internet] [Thesis]. University of Adelaide; 2010. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/2440/63424.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Arentz G. Proteomic and molecular analysis in colorectal cancer: validation of the biomarkers desmin, SET and CK8. [Thesis]. University of Adelaide; 2010. Available from: http://hdl.handle.net/2440/63424
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of Manitoba
23.
Helewa, Ramzi M.
Does geography influence the treatment and outcomes of colorectal cancer in the province of Manitoba?.
Degree: Surgery, 2012, University of Manitoba
URL: http://hdl.handle.net/1993/8151
► Background: Colorectal cancer (CRC) is the third most common cancer in Manitoba. We sought to determine if regional differences exist for treatments, wait times, and…
(more)
▼ Background:
Colorectal cancer (CRC) is the third most common
cancer in Manitoba. We sought to determine if regional differences exist for treatments, wait times, and quality measures for Manitobans with CRC.
Methods: A population-based historical cohort analysis for patients diagnosed with CRC between 2004 and 2006 was undertaken using administrative databases.
Results: 2086 patients were diagnosed with Stage I-IV CRC between 2004 and 2006. Diagnosis wait times and treatment wait times were longer in Winnipeg than rural Manitoba. There were no differences between Winnipeg and rural Manitoba in rates of total colonic examination, adequate lymphadenectomy, and consultations with oncologists. Rural patients with rectal
cancer experienced higher local recurrence and mortality rates than urban patients.
Conclusion: This study establishes population-based benchmarks for the quality of CRC therapy in Manitoba. Minimal geographic differences exist for quality measures. For rectal
cancer local recurrence, rural patients represent an important area for quality improvement initiatives.
Advisors/Committee Members: McKay, Andrew (Surgery) (supervisor), Srinathan, Sadeesh (Surgery) Hardy, Krista (Surgery) Embil, John (Medical Microbiology) (examiningcommittee).
Subjects/Keywords: colorectal cancer; quality; geography
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Helewa, R. M. (2012). Does geography influence the treatment and outcomes of colorectal cancer in the province of Manitoba?. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/8151
Chicago Manual of Style (16th Edition):
Helewa, Ramzi M. “Does geography influence the treatment and outcomes of colorectal cancer in the province of Manitoba?.” 2012. Masters Thesis, University of Manitoba. Accessed January 22, 2021.
http://hdl.handle.net/1993/8151.
MLA Handbook (7th Edition):
Helewa, Ramzi M. “Does geography influence the treatment and outcomes of colorectal cancer in the province of Manitoba?.” 2012. Web. 22 Jan 2021.
Vancouver:
Helewa RM. Does geography influence the treatment and outcomes of colorectal cancer in the province of Manitoba?. [Internet] [Masters thesis]. University of Manitoba; 2012. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/1993/8151.
Council of Science Editors:
Helewa RM. Does geography influence the treatment and outcomes of colorectal cancer in the province of Manitoba?. [Masters Thesis]. University of Manitoba; 2012. Available from: http://hdl.handle.net/1993/8151

Harvard University
24.
Enogieru, Imarhia.
The Association of a Colorectal Cancer Screening Patient Navigation Program With Adherence to Timely Surveillance Colonoscopies.
Degree: Doctor of Medicine, 2018, Harvard University
URL: http://nrs.harvard.edu/urn-3:HUL.InstRepos:41973510
► Purpose: Reduction in incidence and mortality of colorectal cancer (CRC) has been attributed to colonoscopy for detection and removal of precursor lesions/polyps. Post-polypectomy patients are…
(more)
▼ Purpose: Reduction in incidence and mortality of colorectal cancer (CRC) has been attributed to colonoscopy for detection and removal of precursor lesions/polyps. Post-polypectomy patients are often at higher risk of developing cancer and require follow-up surveillance colonoscopy (FSC). Patient navigation (PN) has been effective in improving screening in low income and minority populations; however, the literature is scarce on its effect on timely FSC. Our objectives were to compare the proportions of timely FSCs in patients who had received PN for initial colonoscopy to patients without PN and to identify reasons for non-adherence with FSC in underserved populations.
Methods: In this retrospective, matched cohort study, we reviewed the charts of Massachusetts General Hospital (MGH) Chelsea health center primary care patients who received PN at their initial colonoscopy between 2010-2011 and had abnormal finding requiring surveillance. These patients were matched in a 1:3 ratio by age, gender, race, language and CRC risk category to patients with an abnormal colonoscopy during the same period who required FSC, but were not navigated. The primary outcome was proportion of timely FSC, defined as colonoscopy completed within six months of the recommended date based on the CRC risk score, in navigated vs. non-navigated group. We used a chi-square test for unadjusted comparison and multivariable logistic regression with adjustment for health insurance, education and prior number of annual visits. Our secondary outcome were reasons for non-adherence to timely completion of FSC.
Results: Among 216 patients, 34 (55%) who received PN, completed a timely FSC compared to 82 (53%) in the control group (p=0.881). After adjusting for insurance, education, language and number of annual primary care visits, patients who received PN had similar odds (AOR=1.209, 95% CI 0.622-2.349) of completing a timely surveillance when compared to those who did not receive PN. The reasons for non-adherence with timely FSC were related to patients’ issues: declined, moved/traveled, co-morbidities and death. System and provider barriers included: patient referred but scheduling issues, provider miscommunication and delayed referral.
Conclusions: Navigation in under served patients for initial colonoscopy did not improve odds of timely FSC. Understanding the multiple reasons for non-adherence could guide future initiatives to improve FSC rates in this population.
Scholarly Project
Subjects/Keywords: Colorectal Cancer; Patient Navigation
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Enogieru, I. (2018). The Association of a Colorectal Cancer Screening Patient Navigation Program With Adherence to Timely Surveillance Colonoscopies. (Doctoral Dissertation). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:41973510
Chicago Manual of Style (16th Edition):
Enogieru, Imarhia. “The Association of a Colorectal Cancer Screening Patient Navigation Program With Adherence to Timely Surveillance Colonoscopies.” 2018. Doctoral Dissertation, Harvard University. Accessed January 22, 2021.
http://nrs.harvard.edu/urn-3:HUL.InstRepos:41973510.
MLA Handbook (7th Edition):
Enogieru, Imarhia. “The Association of a Colorectal Cancer Screening Patient Navigation Program With Adherence to Timely Surveillance Colonoscopies.” 2018. Web. 22 Jan 2021.
Vancouver:
Enogieru I. The Association of a Colorectal Cancer Screening Patient Navigation Program With Adherence to Timely Surveillance Colonoscopies. [Internet] [Doctoral dissertation]. Harvard University; 2018. [cited 2021 Jan 22].
Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:41973510.
Council of Science Editors:
Enogieru I. The Association of a Colorectal Cancer Screening Patient Navigation Program With Adherence to Timely Surveillance Colonoscopies. [Doctoral Dissertation]. Harvard University; 2018. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:41973510

Queen Mary, University of London
25.
Nijhuis, Anke.
Roles of microRNAs in diseases of the human gastrointestinal tract.
Degree: PhD, 2015, Queen Mary, University of London
URL: http://qmro.qmul.ac.uk/xmlui/handle/123456789/9547
;
https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.674914
► Crohn's disease (CD) and colorectal cancer (CRC) are major disorders of the intestine. Inflammation in CD often precedes fibrosis and stricture formation, and is linked…
(more)
▼ Crohn's disease (CD) and colorectal cancer (CRC) are major disorders of the intestine. Inflammation in CD often precedes fibrosis and stricture formation, and is linked to increased cancer risk. Hypoxia is a common feature of inflammation and CRC that can severely compromise the effectiveness of current therapy regimes including chemo-radiotherapy and maintenance of remission in CD patients. MicroRNAs (miRNAs) are key regulatory molecules involved in cellular proliferation, apoptosis and fibrosis, which are all modulated by hypoxia. This thesis aims to understand the role of miRNAs in these two intestinal diseases. Microarray profiling identified differentially expressed miRNA in the intestinal mucosa overlying strictured and non-strictured CD tissue samples and in six CRC cell lines cultured in hypoxic conditions compared to normoxia. Validation experiments using qRT-PCR confirmed the differential expression of miR-29a, -29b, -29c, -34a, -493* and -708 in CD mucosa and miR-21, -210, -30d, -320a, -320b and -320c in CRC cell lines. Functionally, over-expression of miR-29b in CD intestinal fibroblasts modulated the down-regulation of collagen I and III transcripts and collagen III protein in a TGF-β-dependent manner. Furthermore, miR-29b induced indirectly the expression of the anti-apoptotic protein Mcl-1 via the cytokines IL-6 and IL-8. A positive correlation between miR-210 and the hypoxia marker CAIX was found in CRC tissue in vivo. Furthermore, HCT116 cells cultured under hypoxia were more resistant to the chemotherapy drug 5-FU than cells grown under normoxia. Knockdown of miR-21 or miR-30d under hypoxia may sensitise CRC cells to 5-FU. CRC cell lines grown under hypoxic conditions present an altered cellular metabolic profile compared to their normoxic counterparts. This thesis has showed that critical miRNAs have a functional role in the progression of two important diseases of the intestine. The work presented highlights the potential of miRNAs as biomarkers and therapeutic targets to improve the clinical management of patients with digestive diseases.
Subjects/Keywords: 616.3; Colorectal Cancer; Crohn's disease
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Nijhuis, A. (2015). Roles of microRNAs in diseases of the human gastrointestinal tract. (Doctoral Dissertation). Queen Mary, University of London. Retrieved from http://qmro.qmul.ac.uk/xmlui/handle/123456789/9547 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.674914
Chicago Manual of Style (16th Edition):
Nijhuis, Anke. “Roles of microRNAs in diseases of the human gastrointestinal tract.” 2015. Doctoral Dissertation, Queen Mary, University of London. Accessed January 22, 2021.
http://qmro.qmul.ac.uk/xmlui/handle/123456789/9547 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.674914.
MLA Handbook (7th Edition):
Nijhuis, Anke. “Roles of microRNAs in diseases of the human gastrointestinal tract.” 2015. Web. 22 Jan 2021.
Vancouver:
Nijhuis A. Roles of microRNAs in diseases of the human gastrointestinal tract. [Internet] [Doctoral dissertation]. Queen Mary, University of London; 2015. [cited 2021 Jan 22].
Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/9547 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.674914.
Council of Science Editors:
Nijhuis A. Roles of microRNAs in diseases of the human gastrointestinal tract. [Doctoral Dissertation]. Queen Mary, University of London; 2015. Available from: http://qmro.qmul.ac.uk/xmlui/handle/123456789/9547 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.674914

University of Oxford
26.
Franklin, James Michael.
Imaging biomarkers for oligometastatic colorectal cancer.
Degree: PhD, 2018, University of Oxford
URL: http://ora.ox.ac.uk/objects/uuid:7d7d68df-3896-485f-af52-363c45fa5e07
;
https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.770648
► Oligometastatic colorectal cancer represents an intermediate disease state potentially treatable with curative intent. Novel treatment strategies are expanding the opportunity to offer local treatment for…
(more)
▼ Oligometastatic colorectal cancer represents an intermediate disease state potentially treatable with curative intent. Novel treatment strategies are expanding the opportunity to offer local treatment for limited metastatic disease. It is therefore increasingly important to define patients likely to benefit from these targeted treatments. Diagnostic imaging is central to patient management, to establish the burden and distribution of metastatic disease. This thesis explores the potential value of novel imaging biomarkers in patients with colorectal liver metastases (CRLM). In a prospective study, perfusion CT (pCT) and dynamic contrast-enhanced MRI (DCE-MRI) were performed prior to resection, and a retrospective series of patients with resected CRLM was collated. Resected metastases were analysed for relevant morphological features and IHC expression. Novel and conventional imaging variables were derived based on CT, MRI, pCT, DCE-MRI and 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET), and their associations with histopathological features, immunohistochemical expression and patient outcomes analysed. A novel subregion analysis based on DCE-MRI data was developed to classify tumour subregions, using a histological reference standard. The results presented in this thesis confirm that the number and distribution of hepatic metastases are prognostic markers for patients with resected CRLM, and that higher SUVmean of liver metastases, and higher SUVmax of the background liver, are potential prognostic biomarkers. Histopathological assessment of resected CRLM highlighted that there is significant between and within patient variability of clinically relevant histopathological features and IHC expression, which would support the potential utility of imaging biomarkers to characterise multi- site disease. Analysis of functional imaging data demonstrated positive correlations between imaging variables and clinically relevant markers of tumour vascularity and metabolism, while subregion analysis of DCE-MRI data produced good spatial correlation with viable and non-viable tumour based on histopathology, with significant differences in derived phamacokinetic parameters between subregions.
Subjects/Keywords: Colorectal cancer; Imaging; Biomarkers
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Franklin, J. M. (2018). Imaging biomarkers for oligometastatic colorectal cancer. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:7d7d68df-3896-485f-af52-363c45fa5e07 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.770648
Chicago Manual of Style (16th Edition):
Franklin, James Michael. “Imaging biomarkers for oligometastatic colorectal cancer.” 2018. Doctoral Dissertation, University of Oxford. Accessed January 22, 2021.
http://ora.ox.ac.uk/objects/uuid:7d7d68df-3896-485f-af52-363c45fa5e07 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.770648.
MLA Handbook (7th Edition):
Franklin, James Michael. “Imaging biomarkers for oligometastatic colorectal cancer.” 2018. Web. 22 Jan 2021.
Vancouver:
Franklin JM. Imaging biomarkers for oligometastatic colorectal cancer. [Internet] [Doctoral dissertation]. University of Oxford; 2018. [cited 2021 Jan 22].
Available from: http://ora.ox.ac.uk/objects/uuid:7d7d68df-3896-485f-af52-363c45fa5e07 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.770648.
Council of Science Editors:
Franklin JM. Imaging biomarkers for oligometastatic colorectal cancer. [Doctoral Dissertation]. University of Oxford; 2018. Available from: http://ora.ox.ac.uk/objects/uuid:7d7d68df-3896-485f-af52-363c45fa5e07 ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.770648
27.
Abdelhady, Rasha.
Characterizing pro-mutagenic O6-alkylguanine adducts in human colorectal tissue.
Degree: PhD, 2018, University of Manchester
URL: https://www.research.manchester.ac.uk/portal/en/theses/characterizing-promutagenic-o6alkylguanine-adducts-in-human-colorectal-tissue(61792200-cb60-425c-b667-1ebe3b2b5192).html
;
https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771360
► Colorectal cancer is the third most commonly diagnosed cancer worldwide. The positive association between red and/or processed meat consumption and human colorectal cancer risk is…
(more)
▼ Colorectal cancer is the third most commonly diagnosed cancer worldwide. The positive association between red and/or processed meat consumption and human colorectal cancer risk is well established potentially via heme-catalysed formation of carcinogenic N-nitrosocompounds (NNOC). These NNOC can form a range of O6- alkylguanine (O6-alkylG) adducts that may increase mutational and cancer risk. The overall aim of this study was to develop a novel approach to characterize the overall load of O6-alkylG adducts in human colorectal DNA using the known action of the DNA repair protein, O6-alkylguanine O6-alkyltransferase (MGMT) to irreversibly transfer the alkyl group from O6-alkylG to the MGMT active site peptide (MGMT-ASP). Incubation of chemically synthesised single (SS) and double stranded (DS) oligodeoxyribonucleotides (ODNs) containing O6-methylguanine (O6-MeG), O6- carboxyethylguanine (O6-CEG), but only DS O6-carboxymethylguanine (O6-CMG) -23 mer containing ODNs with MGMT resulted in MGMT inactivation. There was a preference for repair of DS ODNs. Recorded IC50 values were 0.17+0.02, 0.07+0.01, 15.7+2.1, 27.00+1.70 and 7.50+0.50 nanomolar (nM) for SS O6-MeG, DS O6-MeG, DS O6-CMG, SS O6-CEG, and DS O6-CEG, respectively. This repair was confirmed using a restriction endonuclease site deprotection assay as O6-MeG and O6-CEG inhibition of PstI digestion of ODNs, whilst, O6-CMG inhibited MboI. This inhibition was removed by pre-incubation with MGMT. Alkyl group transfer from these ODNs to a Maltose binding protein-MGMT (MBP-MGMT) fusion protein was demonstrated as alkylated active site peptides (ASPs) were detected using with Matrix assisted laser desorption/ionizationtime of flight (MALDI-TOF). S-methylcysteine (m/z 1329.7), and S-carboxyethylcysteine (m/z 1387.7) modified ASPs were detected following incubation of MBP-MGMT incubated with SS or DS O6-MeG, and O6-CEG ODNs, respectively. Scarboxymethylcysteine (m/z 1373.7) was detected with DS but not SS O6-CMG 23 mer ODN. Only the unmodified MGMT-ASP (m/z 1315.7) was found after incubating MGMT with unmodified ODN. Quantitative mass spectrometry (MS) findings highlighted that MGMT preferentially repaired specified adducts when presented in DS ODNs over SS ones. Temozolomide (TMZ) methylated calf thymus DNA (CT-DNA) and human colorectal cancer DNA samples were incubated with his tagged MGMT fusion protein (his-MGMT) and his-MGMT recovered using Ni-coated beads, digested in situ with trypsin and analysed by MALDI-TOF. MS analysis of tryptic digests of MGMT incubated with methylated CT-DNA revealed methylated MGMT-ASP, detecting as low as 50 fmole of O6-MeG/mg CT-DNA. This approach was applied to 13 human colorectal DNA samples, 12 of them showed evidence of O6 alkylation damage. Of 13 samples, 12 contained O6-MeG, 8 contained O6-CMG and 1 contained O6-HOEtG. A further 7 peaks were detected with a signal/noise (S/N) ratio of >10, potentially, correspond to alkylated MGMT-ASP ions but identities of the alkyl groups are as yet unknown. These results demonstrate proof of…
Subjects/Keywords: O6-alkylguanine adducts; Colorectal cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Abdelhady, R. (2018). Characterizing pro-mutagenic O6-alkylguanine adducts in human colorectal tissue. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/characterizing-promutagenic-o6alkylguanine-adducts-in-human-colorectal-tissue(61792200-cb60-425c-b667-1ebe3b2b5192).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771360
Chicago Manual of Style (16th Edition):
Abdelhady, Rasha. “Characterizing pro-mutagenic O6-alkylguanine adducts in human colorectal tissue.” 2018. Doctoral Dissertation, University of Manchester. Accessed January 22, 2021.
https://www.research.manchester.ac.uk/portal/en/theses/characterizing-promutagenic-o6alkylguanine-adducts-in-human-colorectal-tissue(61792200-cb60-425c-b667-1ebe3b2b5192).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771360.
MLA Handbook (7th Edition):
Abdelhady, Rasha. “Characterizing pro-mutagenic O6-alkylguanine adducts in human colorectal tissue.” 2018. Web. 22 Jan 2021.
Vancouver:
Abdelhady R. Characterizing pro-mutagenic O6-alkylguanine adducts in human colorectal tissue. [Internet] [Doctoral dissertation]. University of Manchester; 2018. [cited 2021 Jan 22].
Available from: https://www.research.manchester.ac.uk/portal/en/theses/characterizing-promutagenic-o6alkylguanine-adducts-in-human-colorectal-tissue(61792200-cb60-425c-b667-1ebe3b2b5192).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771360.
Council of Science Editors:
Abdelhady R. Characterizing pro-mutagenic O6-alkylguanine adducts in human colorectal tissue. [Doctoral Dissertation]. University of Manchester; 2018. Available from: https://www.research.manchester.ac.uk/portal/en/theses/characterizing-promutagenic-o6alkylguanine-adducts-in-human-colorectal-tissue(61792200-cb60-425c-b667-1ebe3b2b5192).html ; https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.771360

University of Edinburgh
28.
Briffa, Romina.
Towards functional multiscale analysis of colorectal cancer.
Degree: PhD, 2014, University of Edinburgh
URL: http://hdl.handle.net/1842/16230
► Background: The five year overall survival rate for colorectal cancer (CRC) patients varies between 38.8% and 59.9%. Selecting patients who are likely to respond to…
(more)
▼ Background: The five year overall survival rate for colorectal cancer (CRC) patients varies between 38.8% and 59.9%. Selecting patients who are likely to respond to therapy remains a clinical and pathological challenge, hence the need for predictive and prognostic biomarkers. The objectives of this study were: 1) to establish which genes were differentially expressed with respect to sensitivity to treatment, 2) to integrate the list of differentially expressed genes with copy number to systematically identify predictive biomarkers, and 3) to establish which genes are commonly gained in the panel of CRC cell lines. As proof of concept of the approach the copy number variations of the identified genes were assessed in a cohort of Dukes’ A and B cancers, in order to analyse the likelihood of these genes acting as useful biomarkers. Methods: Cell viability assays were carried out on a panel 15 CRC cell lines. IC50s were measured for 5-fluoruracil (5-FU), oxaliplatin (L-OHP), and BEZ-235, a PI3K/mTOR inhibitor. We carried out a systematic array-based survey of gene expression and copy number variation in CRC cell lines, and compared these to responses to different treatments. Cell lines were profiled using array comparative genomic hybridisation (aCGH; NimbleGen 135k), Illumina gene expression analysis, reverse phase protein arrays (RPPA), and targeted sequencing of KRAS hotspot mutations. The associations between the biological variables and drug sensitivity were assessed using correlation coefficients, chi-square analysis, and the Mann Whitney-U test. Tissue microarrays (TMA) were constructed for a cohort of CRC patients (n=118) and TRIB1 and MYC amplifications were measured using fluorescence in situ hybridisation (FISH). The protein expression for trib1 and 14 associated biomarkers were investigated using Automated Quantitative Analysis (AQUA) and analysed using the Pearson’s correlation coefficient. Results: Twenty-three regions were frequently gained, and fourteen regions were lost across the cell line panel. Gains were observed at 2p, 3q, 5p, 7p, 7q, 8q, 12p, 13q, 14q, and 17q, and losses at 2q, 3p, 5q, 8p, 9p, 9q, 14q, 18q, and 20p. Frequently gained regions contained EGFR, PIK3CA, MYC, SMO, TRIB1, FZD1, and BRCA2, while frequently lost regions contained FHIT and MACROD2. Gene enrichment analysis showed that differentially expressed genes with respect to treatment response were involved in Wnt signalling, EGF receptor signalling, apoptosis, cell cycle, and angiogenesis. Stepwise integration of copy number and gene expression data yielded 47 candidate genes that were significantly correlated (corrected p-value ≤0.05). Differentially expressed genes common to all three treatment responses included AEBP2, DDX56, MRPL32, MRPS17, MYC, NSMCE2, and TBRG4. TRIB1 (n=76) and MYC (n=81) were amplified (FISH score ≥1.8) in 14.5% and 7.4% of the CRC cohort, respectively. TRIB1 and MYC amplifications were significantly correlated (corrected p-value ≤ 0.0001). Trib1 protein expression in the patient cohort was significantly…
Subjects/Keywords: 616.99; molecular pathology; colorectal cancer
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Briffa, R. (2014). Towards functional multiscale analysis of colorectal cancer. (Doctoral Dissertation). University of Edinburgh. Retrieved from http://hdl.handle.net/1842/16230
Chicago Manual of Style (16th Edition):
Briffa, Romina. “Towards functional multiscale analysis of colorectal cancer.” 2014. Doctoral Dissertation, University of Edinburgh. Accessed January 22, 2021.
http://hdl.handle.net/1842/16230.
MLA Handbook (7th Edition):
Briffa, Romina. “Towards functional multiscale analysis of colorectal cancer.” 2014. Web. 22 Jan 2021.
Vancouver:
Briffa R. Towards functional multiscale analysis of colorectal cancer. [Internet] [Doctoral dissertation]. University of Edinburgh; 2014. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/1842/16230.
Council of Science Editors:
Briffa R. Towards functional multiscale analysis of colorectal cancer. [Doctoral Dissertation]. University of Edinburgh; 2014. Available from: http://hdl.handle.net/1842/16230

University of Gothenburg / Göteborgs Universitet
29.
Zou, Zhiyuan.
Mechanisms of intestinal tumor initiation and progression in ApcMin mouse model of colorectal cancer.
Degree: 2018, University of Gothenburg / Göteborgs Universitet
URL: http://hdl.handle.net/2077/54952
► Colorectal cancer (CRC) is a cancer that occurs in the colon or rectum and is one of the most common cancer forms and a leading…
(more)
▼ Colorectal cancer (CRC) is a cancer that occurs in the colon or rectum and is one
of the most common cancer forms and a leading cause of cancer death in the
Western world. The majority of CRCs are caused by inherited or somatic
mutations in the APC gene. The ApcMin model is driven by a truncating mutation
in the Apc gene and is considered to be one of the best mouse models of CRC. The
aim of this thesis is to uncover novel mechanisms behind the initiation and
progression of intestinal adenomas in ApcMin/+ mice.
Clinical studies suggest that the transcription factor Zfp148 may play a role in
CRC but the importance of Zfp148 for tumor development has not been properly
investigated. We have previously shown that Zfp148 is a potent inhibitor of p53
and hypothesized that Zfp148 deficiency may protect against CRC by increasing
p53-activity. In paper I, we show that deletion of one or both copies of Zfp148
markedly reduces tumor formation in ApcMin/+ mice. The result shows that
Zfp148 controls the fate of newly transformed tumor cells by repressing p53,
and suggests that targeting Zfp148 might be useful in the treatment of colorectal
cancer.
Previous studies show that Zfp148 inhibits activation of p53; however, the
underlying mechanism is not understood. We have previously shown that
transcription of Cdkn2a was increased in Zfp148 deficient MEFs. ARF is one of
two products of Cdkn2a and is a major activator of the p53-pathway. Therefore,
we hypothesized that Zfp148 inhibits p53 by repressing ARF. In paper II, we
tested this hypothesis in mouse embryoblasts (MEFs) and found that Zfp148
regulates cell proliferation and p53 activity by repressing the transcription of
ARF.
Finally, we addressed the role of antioxidants. Clinical studies on the ability of
dietary antioxidants to prevent CRC show inconsistent results. To understand
the effect of antioxidants, we gave two types of dietary antioxidants to ApcMIn/+
mice and investigated tumor development. Our results indicate that dietary
antioxidants have no effect on tumor initiation but accelerate progression of
existing tumors. The result raises concerns about the widespread use of dietary
antioxidants, especially among high risk populations.
Subjects/Keywords: colorectal cancer; ApcMin mouse
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Zou, Z. (2018). Mechanisms of intestinal tumor initiation and progression in ApcMin mouse model of colorectal cancer. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/54952
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Chicago Manual of Style (16th Edition):
Zou, Zhiyuan. “Mechanisms of intestinal tumor initiation and progression in ApcMin mouse model of colorectal cancer.” 2018. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed January 22, 2021.
http://hdl.handle.net/2077/54952.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
MLA Handbook (7th Edition):
Zou, Zhiyuan. “Mechanisms of intestinal tumor initiation and progression in ApcMin mouse model of colorectal cancer.” 2018. Web. 22 Jan 2021.
Vancouver:
Zou Z. Mechanisms of intestinal tumor initiation and progression in ApcMin mouse model of colorectal cancer. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 2018. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/2077/54952.
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
Council of Science Editors:
Zou Z. Mechanisms of intestinal tumor initiation and progression in ApcMin mouse model of colorectal cancer. [Thesis]. University of Gothenburg / Göteborgs Universitet; 2018. Available from: http://hdl.handle.net/2077/54952
Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

University of New Mexico
30.
Woersching, Alex L.
An Assessment of Health Insurance Features as Predictors of Colorectal Cancer Screening.
Degree: College of Pharmacy, 2015, University of New Mexico
URL: http://hdl.handle.net/1928/25764
► Health insurance design influences whether a person will receive health services, including colorectal cancer (CRC) screening, although how insurance design influences utilization is not fully…
(more)
▼ Health insurance design influences whether a person will receive health services, including
colorectal cancer (CRC) screening, although how insurance design influences utilization is not fully explained. By disaggregating types of insurance into discrete organizational and financial features, specific influential factors may be identifiable. This study evaluated insurance features as predictors of CRC screening using data from the 2009, 2010, and 2011 Medical Expenditure Panel Survey. Studied insurance features included three organizational features: whether a persons insurance defined a provider network (DPN), used gatekeeping, and restricted coverage to a DPN; and two financial features: whether a person had a Flexible Spending Account (FSA) and categories of cost-sharing experience during the survey year. The primary outcome studied was whether a person was up-to-date with United States (US) Preventive Services Task Force (USPSTF)-recommended CRC screening. In sensitivity analyses, any previous-year CRC screening was evaluated as an alternative outcome to assess if insurance features more strongly affected short-term screening than longer-term USPSTF screening. Multivariate logistic regression models were devised to separately evaluate each insurance feature. In smaller samples of the Western US, secondary analyses evaluated if insurance features differentially affected CRC screening among Hispanic versus non-Hispanic whites. In the logistic models of the full US samples, organizational insurance features did not significantly predict the USPSTF outcome. A significant, >3% point, increase in any previous-year CRC screening was predicted by having two features, gatekeeping and coverage restricted to a DPN. The third organizational feature, having coverage restricted to a DPN, had a non-significant positive effect. In the Western US analyses, each organizational feature predicted a more favorable change in screening likelihood for Western Hispanic whites than non-Hispanic whites suggesting a possible effect of reducing disparate CRC screening among Hispanics. For the financial features in the full and Western US analyses, having a FSA had a large positive effect in unadjusted models, although the effect did not remain significant in fully-adjusted models. Cost-sharing categories predicted substantial variation in screening likelihood, which was largely mitigated in fully-adjusted models. Further research is needed using causal study designs and datasets with richer detail about insurance design.
Advisors/Committee Members: Borrego, Matthew, Borrego, Matthew, Gonzales, Melissa, van der Goes, David.
Subjects/Keywords: health insurance; colorectal cancer; screening
Record Details
Similar Records
Cite
Share »
Record Details
Similar Records
Cite
« Share





❌
APA ·
Chicago ·
MLA ·
Vancouver ·
CSE |
Export
to Zotero / EndNote / Reference
Manager
APA (6th Edition):
Woersching, A. L. (2015). An Assessment of Health Insurance Features as Predictors of Colorectal Cancer Screening. (Masters Thesis). University of New Mexico. Retrieved from http://hdl.handle.net/1928/25764
Chicago Manual of Style (16th Edition):
Woersching, Alex L. “An Assessment of Health Insurance Features as Predictors of Colorectal Cancer Screening.” 2015. Masters Thesis, University of New Mexico. Accessed January 22, 2021.
http://hdl.handle.net/1928/25764.
MLA Handbook (7th Edition):
Woersching, Alex L. “An Assessment of Health Insurance Features as Predictors of Colorectal Cancer Screening.” 2015. Web. 22 Jan 2021.
Vancouver:
Woersching AL. An Assessment of Health Insurance Features as Predictors of Colorectal Cancer Screening. [Internet] [Masters thesis]. University of New Mexico; 2015. [cited 2021 Jan 22].
Available from: http://hdl.handle.net/1928/25764.
Council of Science Editors:
Woersching AL. An Assessment of Health Insurance Features as Predictors of Colorectal Cancer Screening. [Masters Thesis]. University of New Mexico; 2015. Available from: http://hdl.handle.net/1928/25764
◁ [1] [2] [3] [4] [5] … [47] ▶
.